DHE-45 en es it fr

DHE-45 Brand names, DHE-45 Analogs

DHE-45 Brand Names Mixture

  • No information avaliable

DHE-45 Chemical_Formula

C33H37N5O5

DHE-45 RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

DHE-45 fda sheet

DHE-45 FDA

DHE-45 msds (material safety sheet)

DHE-45 MSDS

DHE-45 Synthesis Reference

No information avaliable

DHE-45 Molecular Weight

583.678 g/mol

DHE-45 Melting Point

No information avaliable

DHE-45 H2O Solubility

No information avaliable

DHE-45 State

Solid

DHE-45 LogP

No information avaliable

DHE-45 Dosage Forms

Liquid

DHE-45 Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

DHE-45 Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

DHE-45 Absorption

Interpatient variable and may be dependent on the administration technique

DHE-45 side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

DHE-45 Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

DHE-45 Organisms Affected

Humans and other mammals